Is meconium screening appropriate for universal use? Science and ethics say no

Advances in Neonatal Care

Volumn 7, Issue 4, 2007, Pages 207-214

  Marcellus, Lenora ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NONE   (Canada)

Author keywords

Ethics; Fetal alcohol syndrome; Meconium screening; Newborn screening; Newborn screening expansion; Prenatal alcohol exposure

Indexed keywords

BIOLOGICAL MARKER;

CHEMISTRY; CHILD; ETHICS; EVIDENCE BASED MEDICINE; FEMALE; FETAL ALCOHOL SYNDROME; HUMAN; INFORMED CONSENT; MECONIUM; METABOLISM; METHODOLOGY; NEWBORN; NEWBORN NURSING; NEWBORN SCREENING; NURSE ATTITUDE; NURSING; NURSING ASSESSMENT; OUTCOME ASSESSMENT; PATIENT ADVOCACY; PATIENT SELECTION; PRACTICE GUIDELINE; PREGNANCY; REPRODUCTIVE RIGHTS; REVIEW; SUBSTANCE ABUSE;

BIOLOGICAL MARKERS; CHILD; EVIDENCE-BASED MEDICINE; FEMALE; FETAL ALCOHOL SYNDROME; HUMANS; INFANT, NEWBORN; INFORMED CONSENT; MECONIUM; NEONATAL NURSING; NEONATAL SCREENING; NURSE'S ROLE; NURSING ASSESSMENT; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT ADVOCACY; PATIENT SELECTION; PRACTICE GUIDELINES; PREGNANCY; PRINCIPLE-BASED ETHICS; REPRODUCTIVE RIGHTS; SUBSTANCE ABUSE DETECTION;

EID: 35148834735     PISSN: 15360903     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ANC.0000286338.90799.99     Document Type: Review

References (37)

1. Bryant K, Horns K, Longo N, Schiefelbein J. A primer on newborn screening. Adv Neo Care. 2004;4:306-317.
2. Caprara D. Fatty acid ethyl esters and hair analysis: biomarkers for alcohol consumption and their possible application in the diagnosis of FASD. J FAS Int. 2003;1e7: 1-3. Available at: http://www.motherisk.org/JFAS/ econtent_archives.jsp?archive_id=2. Accessed December 12, 2006.
3. Gareri J. Fatty acid ethyl esters in meconium: an emerging biomarker for in utero alcohol exposure. J FAS Int. 2003;1e20:1-3.
4. Ostrea E, Romero A, Yee H. Adaptation of the meconium drug test for mass screening. J Pediatr. 2003;122:152-154.
5. Starzomski R. The biotechnology revolution - a brave new world? The ethical challenges of xenotransplantation. In: Storch J, Rodney P, Starzomski R, eds. Toward a Moral Horizon: Nursing Ethics for Leadership and Practice. Toronto, Canada: Pearson Education; 2004:314-338.
6. Clayton E. Issues in state newborn screening. Pediatrics. 1992;90(4):641-646.
7. Health Resources and Services Administration, American Academy of Pediatrics Newborn Screening Task Force. Serving the family from birth to the medical home. Newborn screening: a blueprint for the future - a call for a national agenda on state newborn screening programs. Pediatrics. 2000;106:389-427.
8. Storch J. Nursing ethics: a developing moral terrain. In: Storch J, Rodney P, Starzomski R, eds. Toward a Moral Horizon: Nursing Ethics for Leadership and Practice. Toronto, Canada: Pearson Education; 2004:1-16.
9. National Association of Neonatal Nurses. Code of Ethics. Available at: http://www.nann.org/i4a/pages/index.cfm?pageid=1012. Accessed May 9, 2005.
10. Rodney P, Burgess M, McPherson G, Brown H. Our theoretical landscape: a brief history of health care ethics. In: Storch J, Rodney P, Starzomski R, eds. Toward a Moral Horizon: Nursing Ethics for Leadership and Practice. Toronto, Canada: Pearson Education; 2004:56-76.
11. Ogle K. Ethical framework for neonatal screening: framing the issues for ethical decision-making. Highlights of the 5th Annual Fetal Alcohol Canadian Expertise Roundtable, September 9, 2004. Available at: http://www.knowledge network.ca/know_tool/fasIII/index.html. Accessed May 9, 2005.
12. Gareri J. Questions of ethics: neonatal screening for prenatal alcohol exposure. Highlights of the 5th Annual Fetal Alcohol Canadian Expertise Roundtable, September 9, 2004. Available at: http://www.motherisk.org/ JFAS_documents/FACE.pdf. Accessed May 9, 2005.
13. Beauchamp T, Childress J. Principles of Biomedical Ethics. 5th ed. Oxford: Oxford University Press; 2001.
14. Kunk R. Expanding the newborn screen: terrific or troubling? MCN Am J Matern Child Nurs. 1998;23:266-271.
15. Federman D, Hanna K, Rodriquez L. Responsible Research: A Systems Approach to Protecting Participants. Washington, DC: Institute of Medicine, Committee on Assessing the System for Protecting Human Research Participants; 2002.
16. Hanley W. Newborn screening in Canada - are we out of step? Paediatrics and Child Health. 2005;10:203-207.
17. Witters I, Fryns J. Prenatal diagnosis: clinical aspects. In: Gastmans C, ed. Between Technology and Humanity: The Impact of Technology on Health Care Ethics. Leuven, Belgium: Leuven University Press; 2002:66-79.
18. Blackburn S. Maternal, Fetal, and Neonatal Physiology: A Clinical Perspective. 2nd ed. St. Louis, Mo: Saunders; 2003.
19. Kwong T, Ryan R. Detection of intrauterine illicit drug exposure by newborn drug testing. Clin Chem. 1997;43:235-242.
20. National Institute on Alcohol Abuse and Alcoholism. Alcohol metabolism. Alcohol Alert. 1997; No. 35: PH 371. Available at: http://www.niaaa.nih. gov/publications/aa35.htm. Accessed May 9, 2005.
21. Chan D, Caprara D, Blanchette P, Klein J, Koren G. Recent developments in meconium and hair testing methods for the confirmation of gestational exposures to alcohol and tobacco smoke. Clin Biochem. 2004;37:429-438.
22. Bearer C. Markers to detect drinking during pregnancy. NIAAA News. 2000. Available at: http://www.niaaa.nih.gov/publications/arh25-3/210-218-text. htm. Accessed May 10, 2005.
23. Ostrea E. Understanding drug testing in the neonate and the role of meconium analysis. J Perin Neonatal Nurs. 2001;14:61-82.
24. Indiana State Department of Health. Meconium Screening Program. Available at: http://www.state.in.us/isdh/programs/nbs/MecScrCriteria.htm. Accessed May 9, 2005.
25. Center for Disease Control. Surveillance for disparities in maternal health-related behaviors: selected states pregnancy risk assessment (PRAMS) 2000-2001. MMWR Morb Mortal Wkly Rep. 2004;53:2-12.
26. Canadian Pediatric Society. Joint statement: prevention of fetal alcohol syndrome and fetal alcohol effects in Canada. Paediatrics and Child Health. 1997 (reaffirmed 2002);2:143-145.
27. Committee on Substance Abuse and Committee on Children with Disabilities, American Academy of Pediatrics. Fetal Alcohol Syndrome and alcohol-related neurodevelopmental disorders. Pediatrics. 2000;106:358-361.
28. Chudley A, Conry J, Cook J, Loock C, Rosales T, LeBlanc N. Fetal alcohol spectrum disorder: Canadian guidelines for diagnosis. Canadian Medical Association Journal. 2005;172(Suppl5):S1-S21.
29. Hicks M, Sauve R, Lyon A, Clarke M, Tough S. Alcohol use and abuse in pregnancy: an evaluation of the merits of screening. Can Child Adol Psych Rev. 2003;12:77-80.
30. Roberts G, Nanson J. Best practices: fetal alcohol syndrome/fetal alcohol effects and the effects of other substance use during pregnancy. Ottawa, Canada: Health Canada. Available at: http://www.hc-sc.gc.ca/ahc-asc/alt_formats/ hecs-sesc/pdf/pubs/drugs-drogues/best_practices-meil. Accessed September 1, 2005.
31. Stratton K, Howe C, Battaglia F. Fetal Alcohol Syndrome: Diagnosis, Epidemiology, Prevention and Treatment. Washington, DC: Institute of Medicine, Division of Biobehavioral Sciences and Mental Disorders, Committee to Study Fetal Alcohol Syndrome; 1996.
32. Hildt E. Autonomy and freedom of choice in prenatal genetic diagnosis. Med Health Care Philos. 2002;5:65-71.
33. Armstrong E. Diagnosing moral disorder: the discovery and evolution of fetal alcohol syndrome. Soc Sci Med. 1998;47:2025-2042.
34. Byrd R, Neistadt A, Howard C, Brownstein-Evans C, Weitzman M. Why screen newborns for cocaine: service patterns and social outcomes at age one year. Child Abuse Negl. 1999;23:523-530.
35. Zenewicz D, Kuhn P. Routine meconium screening versus drug screening per physician order: detecting the true incidence of drug-exposed infants. Pediatr Nurs. 1998;24:543-547.
36. Marcus A. Infant hair sample betrays maternal drinking during pregnancy. Health Scout News. 2002.
37. Buus-Frank M. Editorial: I have a dream. Adv Neon Care. 2005;5:1-2.